It encompasses a collection of distinct phenotypes, which can be categorized in three major clinical subtypes: estrogen receptor (ER)/progesterone receptor (PR)-positive, human epidermal growth factor receptor type 2 (HER2)-positive, and triple-negative (ER−/PR−HER2−) breast cancers. Here, ERBB2 is linked to breast cancer.